Agouti-related Peptide (AgRP) in Healthy Mothers and Mothers With Preeclampsia and Their Offspring
Genotype-phenotype Associations of Agouti-related Peptide (AgRP) in Postpartum Period in Preeclamptic and Non-preeclamptic Women and Their Offspring
1 other identifier
observational
84
1 country
1
Brief Summary
The study is focused on the investigation of possible associations between plasma/serum levels of agouti related peptide (AgRP) and its genetic background in healthy women with physiological pregnancy (non-preeclamptic) and women with preeclampsia, in the postpartum period, and in their offspring.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2005
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2006
CompletedFirst Submitted
Initial submission to the registry
January 4, 2010
CompletedFirst Posted
Study publicly available on registry
January 5, 2010
CompletedJanuary 5, 2010
November 1, 2009
1.2 years
January 4, 2010
January 4, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
plasma/serum level of agouti/related peptide in peripheral blood in postpartum mother
2-4 hours postpartum
Plasma level of agouti-related peptide in umbilical cord blood from the newborn
immediately postpartum
Secondary Outcomes (3)
maternal weight gain during pregnancy
using postpartum and peripartum data
birth weight of the newborn
immediately postpartum
maternal preconceptional BMI
anamnestic information
Study Arms (4)
Mothers, preeclampsia
Mothers with preeclampsia diagnosed according to the Guidelines by the Czech Society of obstetrics and gynecology as development of hypertension after the 20th week of pregnancy (systolic blood pressure, ≥140 mmHg; and/or diastolic blood pressure, ≥90 mmHg; measured at rest on two consecutive occasions at least 24 h apart) in previously normotensive women, and the onset of proteinuria (\>300 mg of urinary protein/L over 24 h).
Newborns, physiological pregnancy-delivery
The newborns from the physiological pregnancies with spontaneous, uncomplicated delivery.
Newborns, pregnancy with preeclampsia
Newborns from the pregnancies complicated by preeclampsia.
Mothers, Physiological pregnancy-labour
The cohort of non-preeclamptic mothers with physiological, uncomplicated conception, pregnancy and delivery.
Eligibility Criteria
Patients of the Masaryk university afilliated hospital, Clinic of Obstetrics and Gynecology,hospitalized due to preeclampsia or healthy women with uncomplicated conception, pregnancy and delivery that came to give birth at the Clinic. Along with the mothers, their offspring in included in the study. The study population originated from a static region of the Czech Republic - South Moravia.
You may qualify if:
- For preeclampsia:
- development of hypertension after the 20th week of pregnancy (systolic blood pressure, ≥140 mmHg; and/or diastolic blood pressure, ≥90 mmHg; measured at rest on two consecutive occasions at least 24 h apart) in previously normotensive women, and the onset of proteinuria (\>300 mg of urinary protein/L over 24 h)
- single-fetus pregnancy
- age range 18-35 y
- no preconceptional history of hypertension
- For mother with physiological pregnancies:
- uncomplicated
- spontaneous conception
- single-fetus pregnancy
- age range 18-35 y
- spontaneous uncomplicated delivery
- no history of preconceptional hypertension
You may not qualify if:
- For preeclampsia:
- multiple pregnancy
- preeclampsia superimposed to chronic hypertension preceding pregnancy
- kidney disease
- fetal malformations
- For mothers with physiological pregnancies:
- in vitro fertilization
- fetal malformations
- multiple pregnancy
- events of bleeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Masaryk university affiliated hospital, Clinic of Obstetrics and Gynecology
Brno, Moravia, 625 00, Czechia
Related Publications (4)
Wagner CG, McMahon CD, Marks DL, Daniel JA, Steele B, Sartin JL. A role for agouti-related protein in appetite regulation in a species with continuous nutrient delivery. Neuroendocrinology. 2004;80(4):210-8. doi: 10.1159/000082735. Epub 2004 Dec 13.
PMID: 15604600BACKGROUNDTamura H, Kamegai J, Shimizu T, Ishii S, Sugihara H, Oikawa S. The effect of agouti-related protein on growth hormone secretion in adult male rats. Regul Pept. 2005 Feb 15;125(1-3):145-9. doi: 10.1016/j.regpep.2004.08.012.
PMID: 15582725BACKGROUNDGavrila A, Chan JL, Miller LC, Heist K, Yiannakouris N, Mantzoros CS. Circulating melanin-concentrating hormone, agouti-related protein, and alpha-melanocyte-stimulating hormone levels in relation to body composition: alterations in response to food deprivation and recombinant human leptin administration. J Clin Endocrinol Metab. 2005 Feb;90(2):1047-54. doi: 10.1210/jc.2004-1124. Epub 2004 Nov 16.
PMID: 15546902BACKGROUNDHoggard N, Johnstone AM, Faber P, Gibney ER, Elia M, Lobley G, Rayner V, Horgan G, Hunter L, Bashir S, Stubbs RJ. Plasma concentrations of alpha-MSH, AgRP and leptin in lean and obese men and their relationship to differing states of energy balance perturbation. Clin Endocrinol (Oxf). 2004 Jul;61(1):31-9. doi: 10.1111/j.1365-2265.2004.02056.x.
PMID: 15212642BACKGROUND
Biospecimen
whole blood, umbilical blood
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Julie Bienertova-Vasku, MD.,, Ph.D.
Department of Pathological Physiology, Faculty of Medicine, Masaryk University
- STUDY DIRECTOR
Anna Vasku, prof. Ph.D.
Department of Pathological Physiology, Faculty of Medicine, Masaryk University
- STUDY DIRECTOR
Petr Bienert, Dr.
Department of Pathological Physiology, Faculty of Medicine, Masaryk University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 4, 2010
First Posted
January 5, 2010
Study Start
January 1, 2005
Primary Completion
March 1, 2006
Study Completion
December 1, 2006
Last Updated
January 5, 2010
Record last verified: 2009-11